000 | 01580 a2200457 4500 | ||
---|---|---|---|
005 | 20250514204509.0 | ||
264 | 0 | _c20041220 | |
008 | 200412s 0 0 eng d | ||
022 | _a1351-5101 | ||
024 | 7 |
_a10.1111/j.1468-1331.2004.00912.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aIglseder, B | |
245 | 0 | 0 |
_aInadequate management of cerebrovascular risk factors in participants of a public stroke prevention program in Austria. _h[electronic resource] |
260 |
_bEuropean journal of neurology _cOct 2004 |
||
300 |
_a679-85 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAnticoagulants _xtherapeutic use |
650 | 0 | 4 |
_aAtrial Fibrillation _xcomplications |
650 | 0 | 4 |
_aAustria _xepidemiology |
650 | 0 | 4 |
_aBlood Pressure _xphysiology |
650 | 0 | 4 |
_aCoumarins _xtherapeutic use |
650 | 0 | 4 |
_aDiabetes Mellitus _xepidemiology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypertension _xepidemiology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aOutcome Assessment, Health Care |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 |
_aSalicylic Acid _xtherapeutic use |
650 | 0 | 4 |
_aStroke _xclassification |
700 | 1 | _aMoroder, T | |
700 | 1 | _aStaffen, W | |
700 | 1 | _aLadurner, G | |
773 | 0 |
_tEuropean journal of neurology _gvol. 11 _gno. 10 _gp. 679-85 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1468-1331.2004.00912.x _zAvailable from publisher's website |
999 |
_c15161086 _d15161086 |